Ed Silverman Follow

Every article

1. Friday, October 9, 2026

2. 13:59health
   STAT+: Up and down the ladder: The latest comings and goings STAT (paywall) by Ed Silverman
3. 13:17health
   STAT+: Pharmalittle: We’re reading about a setback for Argenx, Lilly suits over copycat versions of an obesity drug, and more STAT (paywall) by Ed Silverman

4. Thursday, October 8, 2026

5. 13:15health
   STAT+: Pharmalittle: We’re reading about PhRMA suing Trump, biotech frustration over tariffs, and more STAT (paywall) by Ed Silverman story

6. Wednesday, October 7, 2026

7. 14:06health
   STAT+: Merck suffers a setback in Europe over its new Keytruda formulation STAT (paywall) by Ed Silverman
8. 12:56health
   STAT+: Pharmalittle: We’re reading about WHO obesity guidelines for kids, DOJ targeting pharma, and more STAT (paywall) by Ed Silverman story
9. 12:10health
   STAT+: Justice Department targets drugmakers in new directive on combating white-collar fraud STAT (paywall) by Ed Silverman

10. Tuesday, October 6, 2026

11. 13:36health
    STAT+: Pharmalittle: We’re reading about U.S.-funded psychedelic trials, an AstraZeneca R&D center, and more STAT (paywall) by Ed Silverman

12. Monday, October 5, 2026

13. 13:10health
    STAT+: Pharmalittle: We’re reading about a Vaxcyte pneumococcal shot, increasing pharma M&A, and more STAT (paywall) by Ed Silverman story

14. Friday, October 2, 2026

15. 13:11health
    STAT+: Pharmalittle: We’re reading about the 340B drug pilot program, an obesity drug disappointment, and more STAT (paywall) by Ed Silverman
16. 13:20health
    STAT+: Up and down the ladder: The latest comings and goings STAT (paywall) by Ed Silverman

17. Thursday, October 1, 2026

18. 13:26health
    STAT+: Pharmalittle: We’re reading about a plan to lower Medicare drug prices, a Lilly obesity drug, and more STAT (paywall) by Ed Silverman story

19. Wednesday, September 30, 2026

20. 13:35health
    STAT+: Pharmalittle: We’re reading about Beam suing over IP theft, a Trump rule on importing meds, and more STAT (paywall) by Ed Silverman story

21. Tuesday, September 29, 2026

22. 20:41health
    STAT+: Lawmakers urge Trump to rethink new rule that could restrict imported meds from Canada and overseas STAT (paywall) by Ed Silverman story
23. 13:25health
    STAT+: Pharmalittle: We’re reading about Novo licensing a Chinese obesity pill, Merck pulling an antibiotic, and more STAT (paywall) by Ed Silverman story

24. Monday, September 28, 2026

25. 20:45health
    STAT+: Merck discontinues a crucial antibiotic despite concerns over superbug resistance STAT (paywall) by Ed Silverman
26. 13:06health
    STAT+: Pharmalittle: We’re reading about GLP-1s becoming lifestyle drugs, a setback for Merck and Daiichi, and more STAT (paywall) by Ed Silverman

27. Friday, September 25, 2026

28. 17:50health
    STAT+: Licensing deals on generic versions of Roche flu drug aimed at preparing for pandemic STAT (paywall) by Ed Silverman
29. 13:32health
    STAT+: Pharmalittle: We’re reading about a reticent FDA commish nominee, a Novo deal, and more STAT (paywall) by Ed Silverman story
30. 13:38health
    STAT+: Up and down the ladder: The latest comings and goings STAT (paywall) by Ed Silverman

31. Thursday, September 24, 2026

32. 14:57health
    STAT+: Indonesian ruling against ‘patent evergreening’ by pharma industry sends critical message, patient advocates say STAT (paywall) by Ed Silverman
33. 13:21health
    STAT+: Pharmalittle: We’re reading about the FDA commissioner nominee, a Lilly partnership in China, and more STAT (paywall) by Ed Silverman story

34. Wednesday, September 23, 2026

35. 13:20health
    STAT+: Pharmalittle: We’re reading about a closing loophole for importing meds, European competitiveness, and more STAT (paywall) by Ed Silverman

36. Tuesday, September 22, 2026

37. 19:28health
    STAT+: HHS issues new initiatives to reduce animal testing in drug development STAT (paywall) by Ed Silverman
38. 13:14health
    STAT+: Pharmalittle: We’re reading about pharma seeking to protect China deals, a Roche obesity drug, and more STAT (paywall) by Ed Silverman

39. Friday, September 18, 2026

40. 13:29health
    STAT+: Pharmalittle: We’re reading about licensing deals with China, making drugs in space, and more STAT (paywall) by Ed Silverman story
41. 13:38health
    STAT+: Up and down the ladder: The latest comings and goings STAT (paywall) by Ed Silverman story

42. Wednesday, September 16, 2026

43. 13:29health
    STAT+: Pharmalittle: We’re reading about faster FDA approvals, access to experimental drugs in Montana, and more STAT (paywall) by Ed Silverman story

44. Tuesday, September 15, 2026

45. 13:29health
    STAT+: Pharmalittle: We’re reading about a GSK deal for a drug from China, job losses in the U.S., and more STAT (paywall) by Ed Silverman story

46. Monday, September 14, 2026

47. 13:07health
    STAT+: Pharmalittle: We’re reading about another AstraZeneca trial failure, a Novo name change, and more STAT (paywall) by Ed Silverman story

48. Sunday, September 13, 2026

49. 22:30health
    STAT+: Trump’s secretive pharma deals may undermine ‘most-favored nation’ pricing, an analysis suggests STAT (paywall) by Ed Silverman

50. Friday, September 11, 2026

51. 22:17health
    STAT+: Pharma wins a battle over the cost of wastewater treatment in Europe STAT (paywall) by Ed Silverman
52. 15:13health
    STAT+: Up and down the ladder: The latest comings and goings STAT (paywall) by Ed Silverman
53. 13:56health
    STAT+: Pharmalittle: We’re reading about anxious Novartis investors, patent expirations for biologics, and more STAT (paywall) by Ed Silverman story

54. Thursday, September 10, 2026

55. 16:47health
    STAT+: The gifts from pharma companies that keep on giving STAT (paywall) by Ed Silverman
56. 13:01health
    STAT+: Cancer medicines remain in short supply across the U.S., survey finds STAT (paywall) by Ed Silverman
57. 13:09health
    STAT+: Pharmalittle: We’re reading about a Novartis investor seeking a shake-up, a Gilead setback, and more STAT (paywall) by Ed Silverman story

58. Wednesday, September 9, 2026

59. 13:15health
    STAT+: Pharmalittle: We’re reading about an AstraZeneca COPD win, the FDA filling key jobs, and more STAT (paywall) by Ed Silverman story

60. Tuesday, September 8, 2026

61. 13:26health
    STAT+: Pharmalittle: We’re reading about another Novartis trial failure, a Novo Nordisk setback, and more STAT (paywall) by Ed Silverman story
62. 17:38health
    STAT+: FDA warns an API supplier about residue on walls, a corroded product line, and open-toed sandals STAT (paywall) by Ed Silverman